Renal Cell Carcinoma: Surgical & Medical Management of High-Risk Renal Cell Carcinoma

Renal Cell Carcinoma: Surgical & Medical Management of High-Risk Renal Cell Carcinoma: New Paradigms for Treatment

CME Available: https://auau.auanet.org/node/29362

Upon completion of this activity, participants will be able to:
1. State how to manage bleeding complications of robotic partial nephrectomy.
2. Describe the algorithm of Immunotherapy treatment of advanced Renal Cell Carcinoma.
3. Explain how to minimize positive margin rates of robotic partial nephrectomy.

This educational activity is supported by independent educational grants from:
Astellas
AstraZeneca
Bristol-Myers Squibb
Genentech
Merck
Pfizer, Inc.
Sanofi Genzyme